Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

'Program Alignment' Falls Into Place: Everything You Need To Know About US FDA's New Inspectional Approach

Executive Summary

For the medical device industry, FDA's five regional offices – Pacific, Central, Northeast, Southwest, Southeast – will be replaced by three distinct divisions across the US encompassing 20 FDA district offices on May 15. Check out the latest US map from the agency showing where the device divisions will be located, and find out what your firm will be facing at its next facility inspection.

Advertisement

Related Content

US FDA Inspections & FDARA: Will New Law Light The Way For Investigators? Maybe, Experts Say
World of Change Coming For Device Manufacturers: Developments In FDA And International Inspections
'A Sea Change': Device Center Compliance Chief Touts US FDA's Benefit-Risk Concepts – But Will Manufacturers Buy In?
A Stronger Supply Chain: Stryker Tying Process Vendors To MedAccred; Others May Follow Suit As FDA Takes Notice
FDA 'Program Alignment' Means Inspections Consistency To Supplement Industry
Robert Califf Talks Verily, Hopes Gottlieb Can Push Back On Trump
US FDA's 'Program Alignment' Inspection Scheme Begins
US FDA's Program Alignment: Where Should Form-483 Responses Go After May 15?
Will Senate User-Fee Package Be Smooth Sailing Despite Add-Ons?
US FDA's 'Program Alignment' Inspection Scheme Coming Mid-May; Details Still Murky

Topics

Advertisement
UsernamePublicRestriction

Register

MT104827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel